Neurologic Outcomes After Radiation Therapy for Severe Spinal Cord Compression in Multiple Myeloma
Hester Zijlstra(St. Antonius Ziekenhuis), Joseph H. Schwab(Cedars-Sinai Medical Center), Alexander M. Crawford(Harvard University), Nienke Wolterbeek(St. Antonius Ziekenhuis), Diederik H.R. Kempen(OLVG), Noopur Raje(Massachusetts General Hospital), Brendan M. Striano(Harvard University), Daniel G. Tobert(Massachusetts General Hospital), Olivier Q. Groot(University Medical Center Utrecht), Chirayu G. Patel(Harvard University), Diyar Delawi(St. Antonius Ziekenhuis), Jorrit‐Jan Verlaan(Heidelberg University)
Cited by 8
Related Papers
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
|Blood|2001|905
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
|Blood|2010|866
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
|The Lancet Oncology|2019|493